Draw carefully
Can J Biotech
Van den Eynde C, De Clercq K, Van Bree R, Luyten K, Annibali D, Amant F, Han S, Van Nieuwenhuysen E, Baert T, Peeraer K, Voets T, Van Gorp T, Vriens J (2021) TRP channel expression correlates with the epithelial-mesenchymal transition and high-risk endometrial carcinoma
The team reviewed up to three years of medical records beginning when patients started treatment with either a GLP-1 receptor agonist, most often semaglutide, liraglutide, or dulaglutide, or a different diabetes medication called an SGLT2 inhibitor
Tirzepatide vs Semaglutide at a Glance A side-by-side look at how tirzepatide and semaglutide differ in how they work, how they're dosed, what they cost, and where each stands legally
Medication adjustment may be necessary in some cases